Gabelli Funds LLC Veracyte, Inc. Transaction History

Gabelli Funds LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 02, 2019	SELL	$12.0 - $25.76 $596,400 - $1.28 Million	-49,700 Closed	0 $0
Q4 2018 Jan 30, 2019	SELL	$9.15 - $14.85 $460,245 - $746,955	-50,300 Reduced 50.3%	49,700 $625,000
Q3 2018 Nov 02, 2018	BUY	$9.55 - $12.64 $955,000 - $1.26 Million	100,000 New	100,000 $955,000

307

81.6M

134K

13.3K

Ticker VCYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,575,904
Market Cap $2.97B
Description
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...

Get notified when there are updates to the investment portfolio of Gabelli Funds LLC, based on Form 13F filings with the SEC.

Stay updated on Gabelli Funds LLC with notifications on news.